1. Home
  2. RYTM vs NXST Comparison

RYTM vs NXST Comparison

Compare RYTM & NXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • NXST
  • Stock Information
  • Founded
  • RYTM 2008
  • NXST 1996
  • Country
  • RYTM United States
  • NXST United States
  • Employees
  • RYTM N/A
  • NXST N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • NXST Broadcasting
  • Sector
  • RYTM Health Care
  • NXST Industrials
  • Exchange
  • RYTM Nasdaq
  • NXST Nasdaq
  • Market Cap
  • RYTM 5.9B
  • NXST 5.5B
  • IPO Year
  • RYTM 2017
  • NXST 2003
  • Fundamental
  • Price
  • RYTM $97.61
  • NXST $206.36
  • Analyst Decision
  • RYTM Strong Buy
  • NXST Strong Buy
  • Analyst Count
  • RYTM 13
  • NXST 7
  • Target Price
  • RYTM $101.92
  • NXST $217.14
  • AVG Volume (30 Days)
  • RYTM 578.8K
  • NXST 369.9K
  • Earning Date
  • RYTM 08-05-2025
  • NXST 08-07-2025
  • Dividend Yield
  • RYTM N/A
  • NXST 3.60%
  • EPS Growth
  • RYTM N/A
  • NXST 53.49
  • EPS
  • RYTM N/A
  • NXST 19.36
  • Revenue
  • RYTM $156,287,000.00
  • NXST $5,316,000,000.00
  • Revenue This Year
  • RYTM $37.86
  • NXST N/A
  • Revenue Next Year
  • RYTM $72.72
  • NXST $10.12
  • P/E Ratio
  • RYTM N/A
  • NXST $10.66
  • Revenue Growth
  • RYTM 53.55
  • NXST 6.55
  • 52 Week Low
  • RYTM $43.57
  • NXST $141.66
  • 52 Week High
  • RYTM $99.04
  • NXST $212.44
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 73.48
  • NXST 67.87
  • Support Level
  • RYTM $95.30
  • NXST $183.10
  • Resistance Level
  • RYTM $99.04
  • NXST $212.44
  • Average True Range (ATR)
  • RYTM 3.21
  • NXST 6.26
  • MACD
  • RYTM 0.20
  • NXST 1.96
  • Stochastic Oscillator
  • RYTM 90.50
  • NXST 81.05

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. The 2019 merger with Tribune made Nexstar the top broadcast affiliate for both Fox and CBS as well as the number two partner for NBC and number three for ABC. The firm maintains stations in 13 of the top 20 television markets and reaches 68% of US TV households. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

Share on Social Networks: